Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 2716 AL 2730

Endocannabinoid System in Neurological Disorders

Ranieri R, Laezza C, Bifulco M, Marasco D, Malfitano AM.

Recent Pat CNS Drug Discov. 2016;10(2):90-112. doi: 10.2174/1574889810999160719105433.

[Evaluation of a Neuropsychiatric Disorder: From PANDAS to PANS and CANS]

Baytunca MB, Donuk T, Erermiş S.

Turk Psikiyatri Derg. 2016 Summer;27(2):0.

Neurochemical correlation between major depressive disorder and neurodegenerative diseases

Réus GZ, Titus SE, Abelaira HM, Freitas SM, Tuon T, Quevedo J, Budni J.

Life Sci. 2016 Aug 1;158:121-9. doi: 10.1016/j.lfs.2016.06.027. Epub 2016 Jun 28.

The role of the Wnt canonical signaling in neurodegenerative diseases

Libro R, Bramanti P, Mazzon E.

Life Sci. 2016 Aug 1;158:78-88. doi: 10.1016/j.lfs.2016.06.024. Epub 2016 Jun 28.

Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity

Tousley A, Kegel-Gleason KB.

J Huntingtons Dis. 2016 Jun 28;5(2):99-131. doi: 10.3233/JHD-160199.

Molecular Mechanism of Adult Neurogenesis and its Association with Human Brain Diseases

Liu H, Song N.

J Cent Nerv Syst Dis. 2016 Jun 20;8:5-11. doi: 10.4137/JCNSD.S32204. eCollection 2016.

Genetic variation and the D2 dopamine receptor: implications for the treatment of neuropsychiatric disease

Mickey BJ.

Pharmacogenomics. 2016 Jul;17(11):1207-1210. doi: 10.2217/pgs-2016-0087. Epub 2016 Jul 5.

Deutetrabenazine for Treatment of Chorea in Huntington Disease

Geschwind MD, Paras N.

JAMA. 2016 Jul 5;316(1):33-5. doi: 10.1001/jama.2016.8011.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial

Huntington Study Group; Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.

JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.

Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function

Leighton PL, Allison WT.

J Alzheimers Dis. 2016 Jul 6;54(1):3-29. doi: 10.3233/JAD-160361.

Basal Ganglia dysfunctions in movement disorders: What can be learned from computational simulations

Schroll H, Hamker FH.

Mov Disord. 2016 Nov;31(11):1591-1601. doi: 10.1002/mds.26719. Epub 2016 Jul 9.

The Puzzle of Huntington Disease Phenocopies

Dupré N, Rouleau G.

JAMA Neurol. 2016 Sep 1;73(9):1056-8. doi: 10.1001/jamaneurol.2016.2095.

Neurologic features in intermediate allele carriers of Huntington disease

Morrison PJ, Benito-León J.

Neurology. 2016 Aug 9;87(6):556-7. doi: 10.1212/WNL.0000000000002958. Epub 2016 Jul 8.

Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders

Ganai SA, Banday S, Farooq Z, Altaf M.

Pharmacol Ther. 2016 Oct;166:106-22. doi: 10.1016/j.pharmthera.2016.07.001. Epub 2016 Jul 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias